Liquidia Corporation (LQDA) vs Prestige Consumer Healthcare Inc. (PBH)
- Liquidia Corporation LQDA 34.35 −1.24%
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
Liquidia Corporation and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Liquidia Corporation is the larger, with a market value of $3.1B against $2.3B — 1.3× the size. Prestige Consumer Healthcare Inc. trades at the lower P/E: 13.9× against 21.9×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against −1.36%. Liquidia Corporation has the higher net margin (30.7% vs 15.6%) and the higher return on invested capital (121.1% vs 4.70%). Across the 22 metrics below, Liquidia Corporation leads on 12 and Prestige Consumer Healthcare Inc. on 10.
Valuation
Profitability
| Metric | LQDA | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 92.54% | 53.53% | 53.94% |
| Operating margin | 37.39% | 26.26% | 0.00% |
| Net margin | 30.74% | 15.57% | 0.00% |
| Free cash flow margin | 33.42% | 21.30% | 0.00% |
| Return on equity | 131.82% | 9.12% | (0.40%) |
| Return on assets | 35.57% | 4.30% | (3.32%) |
| Return on invested capital | 121.05% | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack